Skip to Content

Franklin Biotechnology Discovery A FBDIX Fund Analysis

| Analyst rating as of

Morningstar’s Fund Analysis FBDIX

Will FBDIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A tough 2021 is a lesson in biotech risk.

Summary

| |

Franklin Biotechnology Discovery benefits from an experienced team, but limited resources and an undifferentiated process earn the fund a Morningstar Analyst Rating of Neutral.

Unlock our full analysis with Morningstar Investor